This site is intended for healthcare professionals
Doctor holding patient
Supportive care in oncology Learning Zone

Supportive care options for cancer

Read time: 80 mins
Last updated:23rd May 2023
Published:26th Aug 2022

Systemic anti-cancer treatments have rapidly evolved from being predominantly chemotherapy and radiotherapy, to include immunotherapies and targeted therapies. With many of these novel treatments, new toxicities and side effects have arisen, necessitating alternative management strategies. To gain full access to our section on side effect management, register for a free Medthority account today, or log in to your existing account.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Systemic anti-cancer treatments have rapidly evolved from being predominantly chemotherapy and radiotherapy, to include immunotherapies and targeted therapies. With many of these novel treatments, new toxicities and side effects have arisen, necessitating alternative management strategies. To gain full access to our section on side effect management, register for a free Medthority account today, or log in to your existing account.

  • Discussion of guideline recommended management strategies with Dr Gary Lyman
  • Management and supportive care for the side effects of chemotherapy, radiation therapy, targeted therapy, and immunotherapy
  • Mechanism of action and associated side effects of anticancer therapies

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Systemic anti-cancer treatments have rapidly evolved from being predominantly chemotherapy and radiotherapy, to include immunotherapies and targeted therapies. With many of these novel treatments, new toxicities and side effects have arisen, necessitating alternative management strategies. To gain full access to our section on side effect management, register for a free Medthority account today, or log in to your existing account.

  • Discussion of guideline recommended management strategies with Dr Gary Lyman
  • Management and supportive care for the side effects of chemotherapy, radiation therapy, targeted therapy, and immunotherapy
  • Mechanism of action and associated side effects of anticancer therapies

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Patient Activation for Managing Cancer Treatment Toxicities

Patient activation, defined as an individual's knowledge, skill and confidence in managing their own health, has gained recognition for its positive impact on outcomes in individuals undergoing cancer treatment41. Research supports the notion that more activated patients monitor their conditions more closely, exhibit greater adherence to treatments, and show increased acceptance of recommended care, resulting in improved clinical outcomes. While this evidence spans different patient populations and various settings, studies focusing specifically on patient activation in cancer patients are limited and often restricted to specific cancer types41.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Systemic anti-cancer treatments have rapidly evolved from being predominantly chemotherapy and radiotherapy, to include immunotherapies and targeted therapies. With many of these novel treatments, new toxicities and side effects have arisen, necessitating alternative management strategies. In this section, learn more about:

  • Discussion of guideline recommended management strategies with Dr Gary Lyman
  • Management and supportive care for the side effects of chemotherapy, radiation therapy, targeted therapy, and immunotherapy
  • Mechanism of action and associated side effects of anticancer therapies

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Welcome: